Dr. Ahluwalia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd
Boston, MA 11794Phone+1 617-726-2862
Education & Training
- Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2015
- Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2011
- Duke University School of MedicineClass of 2008
Certifications & Licensure
- MA State Medical License 2010 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 2 citationsVanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 a...Claire Keating, Lael M Yonker, François Vermeulen, Dario Prais, Rachel W Linnemann
The Lancet. Respiratory Medicine. 2024-12-20 - 20 citationsElexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events.Bonnie Ramsey, Christoph U Correll, David R DeMaso, Edward McKone, Elizabeth Tullis
American Journal of Respiratory and Critical Care Medicine. 2024-02-01 - 21 citationsLong-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least oneallele: 144-week interim results from a 192-week open-...Cori L Daines, Elizabeth Tullis, Stefano Costa, Rachel W Linnemann, Marcus A Mall
The European Respiratory Journal. 2023-12-01
Press Mentions
- MGH Residents and Fellows Make Great Save During Soccer GameJanuary 27th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: